Literature DB >> 3859340

Reduction in the stearic to oleic acid ratio in leukaemic cells--a possible chemical marker of malignancy.

K Apostolov, W Barker, D Catovsky, J Goldman, E Matutes.   

Abstract

Total lipid extracts of peripheral blood cells from patients with chronic leukaemias were analysed for relative values of saturation of the eighteen carbon chain length fatty acids (C 18 FA). The results are expressed as saturation index (C 18 S:C 18 U) of the saturated C 18 FA (stearic acid) over the unsaturated C 18 FA (oleic, linoleic and linolenic acids). The saturation indices of the white blood cells (WBC) and the red blood cells (RBC) in specimens from 14 patients with chronic granulocytic leukaemia (CGL) and 17 patients with chronic lymphocytic leukaemias (CLL) were significantly and consistently lower than control specimens. It is proposed that the relative increase in the unsaturated oleic acid could prove to be a chemical marker of malignancy reflecting a deficient cellular control of the process of stearic acid desaturation. The theoretical implications of the implied increase in membrane fluidity for the cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3859340     DOI: 10.1007/bf00320928

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  21 in total

Review 1.  Fatty acids and immunity.

Authors:  C J Meade; J Mertin
Journal:  Adv Lipid Res       Date:  1978

Review 2.  Regulation of membrane enzymes by lipids.

Authors:  H Sandermann
Journal:  Biochim Biophys Acta       Date:  1978-09-29

3.  Erythrocyte sensitivity to in-vitro lysis in leukaemia.

Authors:  D Catovsky; S M Lewis; D Sherman
Journal:  Br J Haematol       Date:  1971-11       Impact factor: 6.998

4.  The effects of interferon on the fatty acids in uninfected cells.

Authors:  K Apostolov; W Barker
Journal:  FEBS Lett       Date:  1981-04-20       Impact factor: 4.124

5.  Fatty acid desaturation-promoting factor (DPF) induced by interferon.

Authors:  K Apostolov; W Barker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1982-09-24       Impact factor: 6.237

6.  A comparative study of the lipids of plasma membranes of normal cells and those infected and transformed by Rous sarcoma virus.

Authors:  R L Maldonado; H A Blough
Journal:  Virology       Date:  1980-04-15       Impact factor: 3.616

7.  Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro.

Authors:  J W Singer; P J Fialkow; L Steinmann; V Najfeld; S J Stein; W A Robinson
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

8.  The correlation of fatty acid content of infected cells and virions with Newcastle disease virus (NDV) virulence.

Authors:  J I Blenkharn; K Apostolov
Journal:  J Gen Virol       Date:  1981-02       Impact factor: 3.891

9.  Decreased microviscosity of membrane lipids in leukemic cells: two possible mechanisms.

Authors:  M Petitou; F Tuy; C Rosenfeld; Z Mishal; M Paintrand; C Jasnin; G Mathe; M Inbar
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

10.  Reversible increase in the saturation of C18 fatty acids induced by diphtheria toxin in tissue culture cells.

Authors:  K Apostolov; W Barker
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

View more
  11 in total

Review 1.  The potential of interferons in malignant disease.

Authors:  K Okita; T Kaneko
Journal:  Drugs       Date:  1990-01       Impact factor: 9.546

2.  Natural IFN-alpha therapy in hairy-cell leukaemia (namalva-type IFN--Wellferon).

Authors:  C P Worman; A B Nethersell; J M Bottomley; K Apostolov; W Barker; J C Cawley
Journal:  Klin Wochenschr       Date:  1987-07-15

3.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.

Authors:  Yasuo Horie; Akira Suzuki; Ei Kataoka; Takehiko Sasaki; Koichi Hamada; Junko Sasaki; Katsunori Mizuno; Go Hasegawa; Hiroyuki Kishimoto; Masahiro Iizuka; Makoto Naito; Katsuhiko Enomoto; Sumio Watanabe; Tak Wah Mak; Toru Nakano
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

4.  Increased erythrocyte stearic acid desaturation in rats with chemically induced colorectal carcinomas.

Authors:  N A Habib; M J Hershman; R Salem; W Barker; K Apostolov; C B Wood
Journal:  Int J Colorectal Dis       Date:  1987-02       Impact factor: 2.571

5.  Effects of high corn oil diet on preneoplastic murine colons: prostanoid production and lipid composition.

Authors:  N M Robblee; R P Bird
Journal:  Lipids       Date:  1994-01       Impact factor: 1.880

6.  Significant decrease of saturation index in erythrocytes membrane from subjects with non-alcoholic fatty liver disease (NAFLD).

Authors:  Maria Notarnicola; Maria Gabriella Caruso; Valeria Tutino; Caterina Bonfiglio; Raffaele Cozzolongo; Vito Giannuzzi; Valentina De Nunzio; Giampiero De Leonardis; Daniela I Abbrescia; Isabella Franco; Vincenza Intini; Antonella Mirizzi; Alberto R Osella
Journal:  Lipids Health Dis       Date:  2017-08-23       Impact factor: 3.876

7.  Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.

Authors:  A Chaudry; S McClinton; L E Moffat; K W Wahle
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

8.  Manipulation of body fat composition with sterculic acid can inhibit mammary carcinomas in vivo.

Authors:  D E Khoo; B Fermor; J Miller; C B Wood; K Apostolov; W Barker; R C Williamson; N A Habib
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

9.  Stearic acid and carcinogenesis.

Authors:  N A Habib; C B Wood; K Apostolov; W Barker; M J Hershman; M Aslam; D Heinemann; B Fermor; R C Williamson; W E Jenkins
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

10.  Erythrocyte membrane fatty acid profile and saturation index in gallbladder carcinogenesis: a case-control study.

Authors:  Manoj Pandey; Lal B Sharma; Shailesh Singh; Vijay K Shukla
Journal:  World J Surg Oncol       Date:  2003-05-07       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.